Literature DB >> 33584295

Resistance of Food-Maintained Operant Responding to Mechanical Punishment in Rats: Further Evidence for Weak "Affective/Motivational Pain" in Rat Models of Inflammatory and Neuropathic Pain.

S Stevens Negus1, S A Marsh1, E A Townsend1.   

Abstract

Clinically relevant chronic pain is often associated with functional impairment and behavioral depression as an "affective/motivational" sign of pain; however preclinical animal models of inflammatory and neuropathic pain often produce weak evidence of impaired function. We hypothesized that hindpaw mechanical stimulation produced by a requirement to rear on a textured "NOX" plate would punish operant responding in rats treated with intraplantar complete Freund's adjuvant (CFA, a model of inflammatory pain) or the chemotherapeutic paclitaxel (PTX, a model of neuropathic pain) and produce sustained pain-related depression of operant behavior. Male Sprague-Dawley rats were trained under a progressive-ratio (PR) schedule of food-maintained operant responding, then treated with CFA (100 µL in left hindpaw), PTX (2.0 mg/kg IP on alternate days for four total injections; 6.6 mg/kg IV on alternate days for three total injections), or saline vehicle. PR break points and mechanical thresholds for paw withdrawal from von Frey filaments were then tracked for 28 days. Subsequently, rats were tested with the opioid receptor antagonist naltrexone to assess latent sensitization and with the kappa opioid receptor (KOR) agonist U69593 to assess KOR function. CFA produced significant mechanical hypersensitivity for 3 weeks but decreased PR breakpoints for only 1 day. Both IP and IV PTX produced mechanical hypersensitivity for at least three weeks; however, only IV PTX decreased PR breakpoints, and this decrease was not alleviated by morphine. After recovery, naltrexone reinstated mechanical hypersensitivity in CFA- but not PTX-treated rats, and it did not reinstate depression of breakpoints in any group. U69593 dose-dependently decreased PR breakpoints in all groups with no difference between control vs. CFA/PTX groups. These results suggest that rearing on a textured NOX plate was not sufficient to punish operant responding in CFA- and PTX-treated rats despite the presence of sustained mechanical hypersensitivity. The rapid recovery of operant responding could not be attributed to latent sensitization, KOR downregulation, or behavioral tolerance. These results extend the range of conditions under which putative chronic pain manipulations produce weak evidence for depression of operant responding as a sign of the "affective/motivational" component of pain in rats.
Copyright © 2021 Negus, Marsh and Townsend.

Entities:  

Keywords:  Operant; U69,593; complete freund adjuvant; morphine; naltrexone; paclitaxel; punishment

Year:  2021        PMID: 33584295      PMCID: PMC7878562          DOI: 10.3389/fphar.2020.615782

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  39 in total

1.  Progressive ratio as a measure of reward strength.

Authors:  W HODOS
Journal:  Science       Date:  1961-09-29       Impact factor: 47.728

2.  Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats.

Authors:  Marta V Hamity; Stephanie R White; Roxanne Y Walder; Mark S Schmidt; Charles Brenner; Donna L Hammond
Journal:  Pain       Date:  2017-05       Impact factor: 6.961

3.  Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Authors:  Katherine Cone; Janell Lanpher; Abigail Kinens; Philomena Richard; Sarah Couture; Rebecca Brackin; Emily Payne; Kylee Harrington; Kenner C Rice; Glenn W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

4.  A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel.

Authors:  Rosemary C Polomano; Andrew J Mannes; Uraina S Clark; Gary J Bennett
Journal:  Pain       Date:  2001-12       Impact factor: 6.961

5.  Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.

Authors:  Dorothy Cimino Brown; Raymond C Boston; James C Coyne; John T Farrar
Journal:  J Am Vet Med Assoc       Date:  2008-10-15       Impact factor: 1.936

6.  Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds.

Authors:  C Stein; M J Millan; A Herz
Journal:  Pharmacol Biochem Behav       Date:  1988-10       Impact factor: 3.533

7.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

8.  Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.

Authors:  Deniz Bagdas; Pretal P Muldoon; Shakir AlSharari; F Ivy Carroll; S Stevens Negus; M Imad Damaj
Journal:  Neuropharmacology       Date:  2015-11-27       Impact factor: 5.250

Review 9.  The search for translational pain outcomes to refine analgesic development: Where did we come from and where are we going?

Authors:  Rafael González-Cano; Ángeles Montilla-García; M Carmen Ruiz-Cantero; Inmaculada Bravo-Caparrós; Miguel Á Tejada; Francisco R Nieto; Enrique J Cobos
Journal:  Neurosci Biobehav Rev       Date:  2020-03-05       Impact factor: 8.989

10.  Comparison of chemotherapy effects on mechanical sensitivity and food-maintained operant responding in male and female rats.

Authors:  Luke P Legakis; Clare M Diester; Edward A Townsend; Ladan Karim-Nejad; Sidney Stevens Negus
Journal:  Behav Pharmacol       Date:  2020-08       Impact factor: 2.277

View more
  2 in total

1.  Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats.

Authors:  A N Baldwin; M L Banks; S A Marsh; E A Townsend; M Venniro; Y Shaham; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-01-19       Impact factor: 4.530

2.  The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain.

Authors:  Celina A Salcido; Cassie M Argenbright; Tiffany Aguirre; Alex D Trujillo; Perry N Fuchs
Journal:  Front Pain Res (Lausanne)       Date:  2022-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.